Biogen (BIIB) October weekly 267 straddle priced for a move of +/- 4% into the expected release of quarter results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Biogen (BIIB) October weekly 267 straddle priced for a move of +/- 4% into the expected release of quarter results

Long-term Prospects for Biogen’s (BIIB) Aduhelm Remain Key Question - Analyst

October 20, 2021 8:21 AM EDT

Earlier today, Biogen (NASDAQ: BIIB) reported Q3 results: EPS of $4.77, $0.66 better than the analyst estimate of $4.11; revenue for the quarter came in at $2.78 million versus the consensus estimate of $2.67 million.

The company also updated its full-year guidance: EPS of $18.85-$19.35, versus the consensus of $18.61; FY2021... More